Our next meeting will be on November 1-2 at the University of Vermont. Registration is now open!
The deadline for abstract submission is October 10th.
The hotel for the UVM meeting is the Sheraton. A block of rooms has been reserved for the meeting. Reservations must be made by 10/24. There is a 72 hour cancellation period prior to the start of the reservation.
To make an online reservation, visit this website. Alternatively, you may call 1-800-325-3535 and ask for the Islet Club rate.
The Islet Club thanks our previous host, Dr. Gordon Weir, at the Joslin Diabetes Center in Boston, MA.
The purpose of this meeting is to bring together students, postdoctoral fellows, scientists and physicians from academia and industry on the east coast for an informal meeting focused on islet biology and the regulation of glucose homeostasis in the context of type 1 and type 2 diabetes, gestational diabetes and obesity. Scientists in Boston and Ithaca founded the club in 1992, and since then meetings have usually been held twice a year. We attract attendees from Massachusetts, New York, Maine, New Hampshire, Vermont, Montreal, Rhode Island and Toronto. The meeting is structured around 20 minute sessions of which 5-10 minutes are reserved to provide ample time for questions and discussion. Work is presented both by trainees and by established investigators. This provides and excellent forum for students to present their raw data to peers and leaders in the field, providing a chance to obtain valuable feedback for their project and the opportunity to network. The networking is enhanced by a dinner on Saturday evening. Over the years we have obtained consistent feedback from attendees that they enjoy this informal gathering for excellent science and networking opportunities.
Hotel information: Click here to visit the hotel web page. Rooms are based on availability so booking in advance is recommended. Click here to download instructions on parking and further information.
The Islet Club thanks the corporate sponsors for our upcoming Spring 2014 meeting:
BioEnergetics is a full service CRO specializing in mitochondrial research. Who we are: Scientists who are experts in mitochondria that can evaluate, design, execute and interpret results of mitochondrial related study plans. “We design studies to address our client’s scientific and business goals. We are interactive, accessible and maintain close contact with the client.” How we work: By listening to our client’s needs, we evaluate the scientific and company goals before designing any study. We then present a detailed and comprehensive experimental study plan with cost estimate, which allows the client to choose what information they need from their study. Studies can range from mitochondrial function drug screens to in-depth mitochondrial profiling of a lead compound. Why work with us: We offer a diverse set of cell models and system-specific stress conditions. Validated models include cell lines, primary cells, 3D models and human derived tissue samples. We also collaborate with customers on the development of novel custom-designed models. Call for a consult and hear more about our custom research services.
Biomedical Research Models, Inc. (BRM) is a biomedical research company located in Worcester, MA that offers pre-clinical research services (CRO/Contract Research Organization) to the health industry. From early discovery to early toxicology New Drug Application (NDA), BRM is able to conduct in vivo and in vitro phases of nonclinical programs. BRM also developed proprietary rat strains (BB/Wor rat) which are translatable models for the characterization of type 1 and type 2 diabetes as well as immune-related diseases. The FDA Guidance for Industry recommends the BB rat for POC type 1 diabetes studies of prospective therapeutic agents and BRM recently completed the T1D-RAID contract ($4 million over last five years) for NIH to act as a testing facility for novel therapeutic interventions for type 1 diabetes and its complications.
The Islet Club thanks the corporate sponsors for our last meeting in the Spring of 2013:
ALPCO - ALPCO (American Laboratory Products Company) was founded in 1990 as an importer and distributor of high quality research immunoassay kits. Since that time, our primary goals have been to offer a diverse line of assays that appeal to our broad customer base while also providing exceptional customer service and product support. Click here to visit our website.
Seahorse Bioscience - Serving the life sciences industry since 2001, Seahorse Bioscience provides industry-leading analytical instruments, biomanufacturing systems and consumable labware products for biological research and drug discovery. Our customers include scientists at academic institutions, pharmaceutical and biotech organizations, as well as OEM manufacturers of assay kits and lab instruments suppliers.
BioEnergetics is a full-service contract research organization (CRO) located in Boston MA, specializing in mitochondrial related research with superior expertise in pancreatic islet respirometry. We provide an affordable solution for customers looking to determine the bioenergetic profile of their ex-vivo, in-vitro and in-vivo projects, including cell lines (INS1, C2C12, HUH7 and HepG2); primary rodent hepatocytes; rodent and human pancreatic islets; as well as human iPSC derived hepatocytes, cardiomyocytes and neurons. All models can be customized and bioenergetic profiles are determined using the Seahorse Bioscience XF96 and XF24 platforms. Please visit our web site at www.bioenergetics-cro.com and contact us via email at firstname.lastname@example.org or by phone at 1 (617) 953-3490.
The BioCurrents Shared Resource (new name, new leadership) has supported development of biomedical instrumentation at the MBL for over 30 years. The resource continues to advance electrical and electrochemical detection for the non-invasive monitoring of cellular physiology and metabolism. Patrons may make use of instrumentation on the MBL campus or may purchase instrumentation. Over the last decade the resource has paired with prominent members of the Diabetes research community to advance instrumentation suited for metabolic studies on single cells and single islets. Contact Dr. Mark Messerli for more information (email@example.com).